| Literature DB >> 24630631 |
Laurent Villeneuve1, Sylvie Isaac2, Olivier Glehen3, Mathieu Capovilla4, Anne Chevallier5, Sabrina Croce6, Peggy Dartigues7, Juliette Fontaine8, Rachid Kaci9, Gerlinde Lang-Averous10, Marie-Hélène Laverriere11, Agnès Leroux-Broussier12, Eliane Mery13, Flora Poizat14, Séverine Valmary-Degano15, Véronique Verriele-Beurrier16, François-Noël Gilly3, Frédéric Bibeau17.
Abstract
As part of the national 2009-2013 Cancer Plan, and with the support of the National cancer Institute and the French ministry of health, the National network for the treatment of rare peritoneal malignancies (RENAPE) has been organized. Its main objective is to optimize the framework for the healthcare management and treatment of rare peritoneal malignancies. This specific organization covers the whole national territory including clinical expert and specialized structures and should lead to an appropriate treatment based on expertise and proximity. Within the RENAPE network, the RENA-PATH group gathers the pathologists actively involved in the management of rare peritoneal malignancies. The actions of RENA-PATH are focused primarily on the harmonization of pathological diagnostic criteria, reporting of new cases in the RENAPE registry and histology reviewing.Entities:
Keywords: Cancer; Mesothelioma; Mésothéliome; Network; Peritoneum; Pseudomyxoma; Pseudomyxome; Péritoine; Rare; Réseau
Mesh:
Year: 2014 PMID: 24630631 DOI: 10.1016/j.annpat.2014.01.008
Source DB: PubMed Journal: Ann Pathol ISSN: 0242-6498 Impact factor: 0.407